News and events

  • All
  • Events
  • Press releases
  • Publications
All
  • All
  • Events
  • Press releases
  • Publications

ExeVir Bio Appoints a Chief Scientific Officer

Ghent, Belgium, 1 September 2023: ExeVir Bio, a biotech company ...
Read More

ExeVir Bio Awarded EUR 1.6m Grant for Dengue Research

Dengue is a mosquito borne viral infection listed by WHO as top 10 threat for global health The government grant is awarded by Flanders Innovation ...
Read More

Bio International Convention – June 5-8, 2023 – Boston, USA

Our CEO and COO are attending this partnering event in person to explore opportunities to collaborate in delivering new medicines to prevent and treat infectious ...
Read More

Antibody Engineering & Therapeutics Europe 2023 – June 6-8, 2023 – Amsterdam, The Netherlands

Our Head of Preclinical Development is attending this event in person to meet the antibody community.
Read More

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike

Currently circulating SARS-CoV-2 variants have gained complete or significant resistance to all SARSCoV-2-neutralizing antibodies that have been used in the clinic. Such antibodies can prevent ...
Read More